ADAGE CAPITAL PARTNERS GP, L.L.C.

Position in ZVRA — Zevra Therapeutics, Inc.

CIK 1165408 Boston, MA

Position in ZVRA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,864,000

-$600,000 QoQ

Shares Held

200,000

-27.3% QoQ

Ownership

0.338%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ADAGE CAPITAL PARTNERS GP, L.L.C. holds $4,595,586,445 across 121 Biotechnology names. ZVRA ranks #111 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	5,475,611	$532,503,169
2	RPRX	Royalty Pharma plc	7,480,633	$358,845,965
3	CNTA	Centessa Pharmaceuticals plc	8,925,010	$354,501,397
4	ROIV	Roivant Sciences Ltd.	12,794,097	$354,396,486
5	TNGX	Tango Therapeutics, Inc.	12,809,485	$267,974,426
6	PRAX	Praxis Precision Medicines, Inc.	815,739	$262,822,948
7	INSM	INSMED Inc	900,000	$147,168,000
8	AXSM	Axsome Therapeutics, Inc.	737,578	$124,665,433

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,864,000	200,000	-27.3%	Shares	Sole	2026-05-15
2025-12-31	$2,464,000	275,000	-87.6%	Shares	Sole	2026-02-17
2025-09-30	$21,159,750	2,225,000	-46.6%	Shares	Sole	2025-11-14
2025-06-30	$36,720,080	4,168,000	+15.2%	Shares	Sole	2025-08-14
2025-03-31	$27,098,820	3,618,000	-0.9%	Shares	Sole	2025-05-15
2024-12-31	$30,441,000	3,650,000	+462.4%	Shares	Sole	2025-02-14
2024-09-30	$4,504,060	649,000	—	Shares	Sole	2024-11-14
No filing history on record for this holder in this stock.